To Top

Community

Andrew Bulpin

Andrew Bulpin is Executive Vice President of Process Solutions for the life science business of Merck KGaA, Darmstadt, Germany, and is based in Bedford, MA. He joined the organization in 2006 as Vice President of Upstream Processing and later assumed leadership of the Services and Solutions business. He has also served as Global Head of Sales for Pharmaceutical Chemical Solutions.

Contribution
Biologic

Q: If You Could Have One Piece of Biologic Manufacturing Equipment Improved, What Would It Be and Why?

PAP-Q2-17-RT-001
Roundtable

Q: How is Growth in the Biosimilars Market Impacting the Development of New Biologics Manufacturing Equipment Technologies?

PAP-Q2-17-RT-003
Roundtable

Q: What is the Most Significant Recent Advancement in Downstream Bioprocessing Technology? Why is it so Important?

PAP-Q2-17-RT-002